Angiotech Pharmaceuticals, Inc. (TSX:ANP) posts loss of $7.8 million or nine cents per share in third quarter, down from $622.4 million or $7.31 a share in third quarter of 2008 when the company wrote down the value of its goodwill assets by $612.9 million. Revenue from all sources fell to $63.2 million as royalty revenue fell, from $68.4 million a year ago.